<DOC>
	<DOCNO>NCT00436748</DOCNO>
	<brief_summary>The primary objective study follow : 1 . To test proportion participant achieve hemoglobin value great equal 10.0 g/dL time point first dose study great 0.8 administer de novo darbepoetin alfa week ( QW ) treatment anemia pediatric patient chronic kidney disease receive receive dialysis , 2 . To test proportion participant achieve hemoglobin value great equal 10.0 g/dL time point first dose study great 0.8 administer de novo darbepoetin alfa every 2 week ( Q2W ) treatment anemia pediatric patient chronic kidney disease receive receive dialysis .</brief_summary>
	<brief_title>Study Assess Darbepoetin Alfa Dosing Correction Anemia Pediatric Patients With Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<criteria>Current diagnosis Chronic Kidney Disease , either receive receive dialysis Anemic , two consecutive screen hemoglobin value draw least 7 day apart &lt; 11.0 g/dL Transferrin saturation ( Tsat ) great equal 20 % Any erythropoiesis stimulating agent ( ESA ) use within 12 week prior randomization hematologic disorder upper low gastrointenstinal bleeding within 6 month prior randomization uncontrolled hypertension prior history ( within 12 week prior randomization ) acute myocardial ischemia , hospitalization congestive heart failure , myocardial infarction , stroke transient ischemic attack prior history ( within 6 month prior randomization ) thromboembolism</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Anemia</keyword>
	<keyword>Nephrology</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Peritoneal Dialysis</keyword>
	<keyword>Chronic Renal Insufficiency</keyword>
</DOC>